Anaplastic Oligodendroglioma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Active, not recruiting
  • High Grade Glioma
  • +3 more
  • Regadenoson 0.05mg
  • +6 more
  • Birmingham, Alabama
  • +2 more
2022-04-07
Apr 7, 2022
S
Recruiting
  • Anaplastic Astrocytoma
  • +55 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
2022-04-01
Apr 1, 2022
O
N
Active, not recruiting
  • Diffuse Astrocytoma
  • +21 more
  • Orange, California
  • +56 more
2022-03-02
Mar 2, 2022
P
Active, not recruiting
  • Medulloblastoma
  • +7 more
  • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
  • +2 more
  • Buffalo, New York
    Roswell Park Comprehensive Cancer Center
2022-02-15
Feb 15, 2022
C
Recruiting
  • Central Nervous System Neoplasms
  • +22 more
  • Bethesda, Maryland
    National Institutes of Health
2022-03-01
Mar 1, 2022
P
Recruiting
  • Glioblastoma Multiforme
  • +5 more
  • Los Angeles, California
  • +12 more
2022-01-27
Jan 27, 2022
N
Completed
  • Glioma
  • +7 more
  • Neural stem cells loaded with an oncolytic adenovirus
  • Duarte, California
  • +1 more
2022-01-10
Jan 10, 2022
M
Recruiting
  • Anaplastic Astrocytoma, IDH-Wildtype
  • +8 more
  • Quality-of-Life Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-17
Nov 17, 2021
N
Active, not recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Los Angeles, California
  • +11 more
2021-10-20
Oct 20, 2021
S
Recruiting
  • Medulloblastoma
  • +7 more
  • Saint Petersburg, Florida
  • +1 more
2021-09-17
Sep 17, 2021
I
Active, not recruiting
  • Malignant Glioma
  • +10 more
  • Polio/Rhinovirus Recombinant (PVSRIPO)
  • Durham, North Carolina
    Duke University Medical Center
2021-07-12
Jul 12, 2021
D
Recruiting
  • Astrocytoma
  • +8 more
    • Boston, Massachusetts
    • +3 more
    2021-05-30
    May 30, 2021
    N
    Recruiting
    • Diffuse Astrocytoma
    • +22 more
    • Phoenix, Arizona
    • +16 more
    2021-04-16
    Apr 16, 2021
    O
    Recruiting
    • Grade II Glioma
    • +7 more
    • Microdevice
    • Boston, Massachusetts
      Brigham and Women's Hospital
    2021-02-22
    Feb 22, 2021
    A
    Active, not recruiting
    • Brain Tumor, Recurrent
    • +4 more
    • Cytoreductive surgery
    • +2 more
    • New York, New York
    • +1 more
    2021-01-06
    Jan 6, 2021
    U
    Withdrawn
    • Anaplastic Oligodendroglioma
    • +2 more
    • Wear novoTTF-200A
    • Quality-of-Life Assessment
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    2020-12-08
    Dec 8, 2020
    E
    Active, not recruiting
    • Glioblastoma
    • +2 more
    • RRx-001 dose escalation with TMZ + RT
    • +3 more
    • San Francisco, California
    • +2 more
    2020-07-21
    Jul 21, 2020
    M
    Completed
    • Anaplastic Astrocytoma
    • +3 more
    • Carcinoembryonic Antigen-Expressing Measles Virus
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic
    2019-12-31
    Dec 31, 2019
    N
    Completed
    • Glioblastoma Multiforme
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2019-12-11
    Dec 11, 2019
    N
    Terminated
    • Low Grade Glioma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2018-07-03
      Jul 3, 2018
      T
      Completed
      • Glioblastoma
      • +3 more
      • Toca 511 vector
      • Toca FC
      • Duarte, California
      • +9 more
      2018-05-16
      May 16, 2018
      T
      Completed
      • Glioblastoma Multiforme
      • +3 more
      • Toca 511 vector
      • Toca FC
      • Los Angeles, California
      • +7 more
      2018-05-16
      May 16, 2018
      T
      Completed
      • Glioblastoma Multiforme
      • +3 more
      • Toca 511
      • Toca FC
      • Irvine, California
      • +5 more
      2018-05-16
      May 16, 2018